Recent Topics
RxFiles 15th Edition Table of Contents with links
RxFiles COPD Landing Page
RxFiles Kidney Landing Page
Anti-amyloid Medication for Alzheimer's Disease- Overview of Landmark Trials 2025
CLARITY AD- Lecanemab in Early Alzheimer's Disease 2023
CONFIDENCE- Simultaneous Initiation of Finerenone with Empagliflozin in CKD and Diabetes 2025
COPD 3 Device Inhaler Colour Comparison Chart
COPD Landmark Trials- Triple Therapy Overview (IMPACT, ETHOS, TRIBUTE) 2026
COPD Newsletter 2026
COPD Q&A Summary- Frequently asked questions 2026
EMERGE and ENGAGE- Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease 2022
EMPA-KIDNEY- Empagliflozin- with CKD, with or without Type 2 Diabetes 2025
ETHOS- Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD 2020
FIDELIO-DKD- Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes 2020
FIDELITY Pooled Analysis 2022
FIGARO-DKD- Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease 2021
FINEARTS-HF: Finerenone vs Placebo with Mildly Reduced or Preserved Ejection Fraction 2024
FLOW- Effects of Semaglutide on Chronic Kidney Disease in T2DM 2024
IMPACT- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD 2018
Kidney Health – Frequently Asked Questions 2025
Rumour has it that statins cause muscle aches, but do they really 2025
STEP 9- Semaglutide in persons with obesity and knee osteoarthritis 2024
SUNSET- Long-Term Triple Therapy (TT) De-escalation to Indacaterol-Glycopyrronium Breezhaler in COPD
TRAILBLAZER ALZ 2- Donanemab in Early Symptomatic Alzheimer's Disease 2023
TRIBUTE- Triple Inhaled vs Dual LABA-LAMA Inhaled Therapy in Severe to Very-Severe COPD 2018
What's New or Changed?
WISDOM- Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD 2014
RxFiles 15th Ed.

Aug 2025

Geri-RxFiles 4th Ed.

May 2024

Note: This website is designed for healthcare professionals. It is not intended to replace the relationship between patient & physician or health care provider.


Our Resources
Book Information
Cardiology
Dermatology
Diabetes Mini-book
EENT (Eye/Ear/Nose/Throat)
Endocrine & Metabolic; Diabetes, etc.
Gastrointestinal
Genitourinary
Geri-RxFiles
Hematology
Indexes, Abbreviations & References
Infectious Disease
Long Term Care (LTC)
Miscellaneous
Miscellaneous - Other Drug/Therapeutic Areas
Musculoskeletal & Connective Tissue
Nephrology
Neurology
Obs & Gyne
Over The Counter (OTC) & Herbal Medications
Pain Management
Patient Information / Tools
Psychiatry
Respiratory
Smoking Cessation
Substance Abuse, Dependency & Addiction


It's all in the detail!!!

Last Modified: Apr 2020
-------------------------------
RxFiles: an intersecting point for independent drug information, education, evidence based medicine, clinical experience, medication effectiveness, adverse events, NNTs, NNHs, critical appraisal, practical drug use pearls, and a friendly dynamic interactive clinical resource learning activity to promote best practice in drug therapy decision making.  Serving physicians, pharmacists, nurse practitioners and other health professionals through academic detailing as well as our drug comparison charts book, iPad/iPhone app, android app, CFP journal case contributions and RxFiles online resources.  Thank you to  the many family physicians, specialists, pharmacists, and others throughout Canada and abroad who assist with development and review of our materials.  You help us change the world of drug therapy decision making for the better!!! Sincerely, Loren Regier, for the RxFiles Team.


Login
Don't have an account? Sign up now.
Forgotten your password?

Join Our Email List: What's New at RxFiles?

Follow Us
Type 2 Diabetes Q&A - Patient Booklet
Product Image

An information booklet for patients with type 2 diabetes.